Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIVE FUSION vs VISMED Multi for Dry Eye
NCT02117687Phase 4Completed
- Sponsor
- Allergan
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of carboxymethylcellulose + glycerin in dry eye syndrome (DED) (2 arms), sponsored by Allergan. Primary endpoint: Change From Baseline in Global Ocular Staining Score in the Study Eye at Day 35. Started May 2014; status: completed.
02
Drugs
carboxymethylcellulose + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02117687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117687.